ISKCON and Peking University Shenzhen Hospital signed a memorandum of cooperation
Article Author：admin
Category：Coperate News
Reading：597
On November 20, 2014, Shenzhen Yishi Kangning Biotechnology Co., Ltd. and Peking University Shenzhen Hospital (Peking University Hospital) signed a memorandum on the cooperation of ACTL anti-tumor cell immune technology. On the same day, Professor Liu Yong, Chief Scientist of ISKCON, was specially hired as a visiting professor by Peking University Hospital.
In a warm and friendly atmosphere, the two parties conducted in-depth discussions on the research and development, clinical trial research and clinical application of ACTL anti-tumor cell immune technology, and exchanged views on future cooperation. Both parties agreed that the anti-tumor cell immunotherapy There are broad prospects for cooperation in scientific research and clinical applications.
During the exchange, Secretary Chen Yun issued a letter of appointment to Professor Liu Yong for appointing Professor Liu Yong as a visiting professor at Peking University Shenzhen Hospital. Subsequently, Professor Liu Yong and Deputy General Manager Wang Kun signed a memorandum of cooperation with Peking University Hospital on behalf of ISKCON.
Professor Liu Yong was hired as a visiting professor at Peking University Shenzhen Hospital
The signing of this memorandum is conducive to the comprehensive cooperation between ISKCON and Peking University Hospital in the research and development and clinical application of anti-tumor immunotherapy, and will greatly promote the development and technological upgrading of ACTL technology.
In addition to the conversation, Professor Liu Yong also shared his many years of experience and experience in the development and clinical treatment of ACTL anti-tumor cell immunotherapy technology. ISKCON expects that the cooperation with Peking University Hospital will push the ACTL technology to a new milestone, so that the technology can better benefit society.
Professor Liu Yong exchanged ACTL technology with experts from Peking University Hospital
